Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergic reaction warning for OTC vaginal contraceptives proposed by FDA in TFM.

This article was originally published in The Tan Sheet

Executive Summary

OTC VAGINAL CONTRACEPTIVE ALLERGIC REACTION WARNING is proposed by FDA in a tentative final monograph published in the Feb. 3 Federal Register. "Consumers should be warned about possible allergic reactions such as burning and itching that may occur when using" vaginal contraceptives, the agency said. FDA added that the warning should also advise consumers to discontinue use of the product if such reactions occur.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel